Mahamaya Lifesciences Ltd vs Nacl Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Mahamaya Lifesciences Ltd is ₹ 180 as of 04 May 12:00 . The P/E Ratio of Mahamaya Lifesciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of NACL Industries Ltd changed from 14.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Mahamaya Lifesciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of NACL Industries Ltd changed from ₹ 745.63 crore on March 2021 to ₹ 2047 crore on March 2025 . This represents a CAGR of 22.39% over 5 years The revenue of Mahamaya Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of NACL Industries Ltd for the Dec '25 is ₹ 318.28 crore as compare to the Sep '25 revenue of ₹ 456.9 crore. This represent the decline of -30.34% The ebitda of Mahamaya Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of NACL Industries Ltd for the Dec '25 is ₹ 6.75 crore as compare to the Sep '25 ebitda of ₹ 27.24 crore. This represent the decline of -75.22% The net profit of Mahamaya Lifesciences Ltd changed from ₹ 5.53 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The net profit of NACL Industries Ltd changed from ₹ -20.8 crore to ₹ -10.16 crore over 7 quarters. This represents a CAGR of -33.60% The Dividend Payout of Mahamaya Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of NACL Industries Ltd changed from 15.61 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002.
Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016.
The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre. The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
The Company began the journey by focusing on import and registration of vital pesticide molecules.
It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India.

About NACL Industries Ltd

NACL Industries Limited (Earlier known as Nagarjuna Agrichem Limited) was incorporated in November, 1986 to engage in hire purchase, leasing and deposit mobilisation.
The Company changed its name from Nagarjuna Agrichem Limited to NACL Industries Limited on September 4, 2017.
The Company is in the business of crop protection and manufactures both Technicals (Active Ingredient) and Formulations.
It manufactures pesticides, insecticides, acaricides, herbicides, fungicides and other plant growth chemicals.
NACL Industries has now become part of the Murugappa Group, Rs 778 billion conglomerate. In Oct.'94, it came out with a public issue of 23.70 lac shares at a premium of Rs 5, aggregating Rs 3.56 cr, to part-finance a Rs 24-cr project to manufacture monocrotophos (MCP) technicals and MCP formulations.

FAQs for the comparison of Mahamaya Lifesciences Ltd and NACL Industries Ltd

Which company has a larger market capitalization, Mahamaya Lifesciences Ltd or NACL Industries Ltd?

Market cap of Mahamaya Lifesciences Ltd is 425 Cr while Market cap of NACL Industries Ltd is 3,779 Cr

What are the key factors driving the stock performance of Mahamaya Lifesciences Ltd and NACL Industries Ltd?

The stock performance of Mahamaya Lifesciences Ltd and NACL Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mahamaya Lifesciences Ltd and NACL Industries Ltd?

As of May 4, 2026, the Mahamaya Lifesciences Ltd stock price is INR ₹182.0. On the other hand, NACL Industries Ltd stock price is INR ₹161.4.

How do dividend payouts of Mahamaya Lifesciences Ltd and NACL Industries Ltd compare?

To compare the dividend payouts of Mahamaya Lifesciences Ltd and NACL Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.